在绝经后患有骨质疏松症的女性中,有或没有糖尿病的女性中,使用佐莱德龙酸的五年骨折结果
Somdatta Giri1, Govindarajalou Ramkumar2, Jayaprakash Sahoo1
1Endocrinology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
概括
这项研究发现,每年使用佐莱德酸盐治疗在5年内,在患有或没有2型糖尿病的绝经后妇女之间,骨折发生率没有显著差异. 骨矿物质密度在两组中同样有所改善.
科学领域:
- 内分泌学 在内分泌学.
- 老年学是一门学科.
- 整形外科 整形外科 整形外科
背景情况:
- 索莱德酸盐对骨质疏松症有效,特别是当骨的循环量很高时.
- 2型糖尿病 (T2DM) 与骨代谢的改变和骨质疏松症治疗的潜在有效性降低有关.
- 索莱德酸对患有T2DM的绝经后妇女骨折风险的影响尚不清楚.
研究的目的:
- 为了评估和比较骨结局,特别是骨折发生率,在经期五年内,在经期更年期后患有骨质疏松症的女性中,有或没有T2DM接受佐勒德龙酸治疗.
- 作为次要结果,评估骨矿物质密度 (BMD) 和骨周转标记 (BTM) 的变化.
主要方法:
- 一项前性队列研究,涉及患有骨质疏松症的绝经后妇女 (BMD T-score ≤-2.5).
- 参与者被分为T2DM和非T2DM组,所有参与者每年都接受佐勒德罗纳特 (4毫克),和胆醇.
- 骨折史和脊椎骨折通过放射图每年至少在5年内进行评估.
主要成果:
- 在150名完成5年的女性中,发生了20例新骨折 (12.7%的T2DM组与8.0%的非T2DM组相比).
- 在T2DM组中,骨折的相对风险为1.58 (95% CI:0.60-4.13,p=0.2),不具有统计学意义.
- 两组都在骨硬化方面表现出相似的改善,尽管T2DM组的BTM基线较低.
结论:
- 在5年内每年服用佐莱德龙酸治疗并没有导致T2DM和没有T2DM的绝经后妇女之间骨折发生率的统计学上显著差异.
- 在两组中都观察到可比的BMD增长,这表明T2DM中骨质或骨折愈合机制的潜在差异.
- 该研究的发现受到低数量的骨折事件和广泛的置信区间的限制,需要进一步调查.
更多相关视频
07:12Semiautomated Longitudinal Microcomputed Tomography-based Quantitative Structural Analysis of a Nude Rat Osteoporosis-related Vertebral Fracture Model
Published on: September 28, 2017
8.7K
04:19Minimally Invasive Treatment for Thoracolumbar Burst Fracture Using Sagittal Alignment Screws and A Trauma Reduction Device
Published on: November 8, 2024
1.5K
相关概念视频
Fractures: Bone Repair
6.1K
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
6.1K
Bone Disorders
5.8K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.8K
Osteoclasts in Bone Remodeling
4.5K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.5K
Role of Vitamins in Maintaining Bone Health
5.9K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
5.9K
Bone Remodeling
40.7K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.7K
